Naor Blankleder, 29, thought he had beat bone cancer but now it has spread to his lungs and his best chance to survive lies with doctors and researchers at Memorial Sloan Kettering
Recognition will allow for expedited permits, the company says in TASE filing; it's given when devices can help treat life-threatening or seriously debilitating ailments
KAHR's leading drug candidate, now in clinical trials, is based on a compound that targets cancer cells, weakens their defenses and activates a local immune response
Israeli researchers discover specific type of white blood cells thatcan be engineered to attack solid tumors, with fewer side effects than chemotherapy
Recent comments